“SkyQuest Technology Group has recently published a comprehensive Digital Pathology Market report, offering a detailed analysis of the product landscape and industry scope while providing insights into the market outlook and future trends from 2025 to 2032. The global digital pathology market is a fast-growing industry in the medical diagnostics and research sector as there are rising needs for more efficient and accurate diagnostic technology. Digital pathology involves the digitization and analysis of pathology specimens to enable facilitated collaboration among pathologists, more accurate diagnoses, and accelerated turnaround time.
Global Digital Pathology Market size was valued at USD 0.97 billion in 2023 and is poised to grow from USD 1.05 billion in 2024 to USD 1.91 billion by 2032, at a CAGR of 7.8% during the forecast period (2025-2032).
One of the major drivers of the digital pathology industry is the increasing need for personalized medicine, which necessitates more targeted and accurate diagnostics. Furthermore, the rising incidence of cancer and other lifestyle diseases is fueling the demand for more effective diagnostic equipment. The use of artificial intelligence and machine learning technologies in digital pathology is also likely to propel market growth, as these technologies have the ability to improve diagnostic accuracy and efficiency. Nevertheless, the market has its challenges. The cost of digital pathology systems is high, and they require skilled professionals to handle them, which could limit adoption, especially in developing countries.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/digital-pathology-market
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Digital Pathology Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Global Digital Pathology Market is segmented by Product, Type, Application, End-use and region.
Based on Product, the market is segmented into Scanners, Software, Deployment Model and Storage System.
Based on Type, the market is segmented into Human Pathology and Veterinary Pathology.
Based on Application, the market is segmented into Drug Discovery & Development, Academic Research and Disease Diagnosis.
Based on End-use, the market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Digital Pathology Market – Regional Analysis:
Due to its highly developed healthcare systems, sophisticated technology uptake and substantial investment in research and development, North America is the global leader in digital pathology. The region has an abundance of top-notch tech firms and an ecosystem which encourages growths in digital pathology innovations. Also, the North American healthcare services are directed towards enhancing accuracy in diagnosis as well as efficiency; thus, fueling the need for these digital solutions.
The fastest growth of any region in the global digital pathology market trade is Asia-Pacific, due to advancements made in its healthcare systems, growing capital outlay on biomedical machineries and enhancing diagnostic operations. In this part of the earth, the high number of individuals and the rising rates of persistent illnesses lead to a need for effective diagnostic measures that are also precise.
Top Market Players in Digital Pathology Market are:
Koninklijke Philips N.V.
Leica Biosystems (Danaher Corporation)
Roche Diagnostics (F. Hoffmann-La Roche)
Hologic, Inc.
Hamamatsu Photonics
3DHISTECH
GE Healthcare
Akoya Biosciences, Inc.
Fujifilm Holdings Corporation
Apollo Enterprise Imaging
Olympus Corporation
Mikroscan Technologies
Inspirata
PerkinElmer
Huron Digital Pathology
Sectra AB
PathAI
Indica Labs
Nikon Corporation
Visiopharm
Recent Developments in Digital Pathology Market:
In April 2025, Indica Labs and Visiopharm partnered to integrate Visiopharm’s discovery image analysis tools into Indica’s HALO Link platform. This integration enables the creation of a tailored digital pathology ecosystem focused on advanced image analytics and collaborative research capabilities.
In March 2025, Royal Philips expanded its collaboration with Ibex Medical Analytics and launched an updated version of its IntelliSite Pathology Solution (PIPS). This move aims to accelerate the adoption of AI-powered digital pathology solutions to help address the rising global shortage of pathologists and meet the growing demand driven by increased cancer diagnoses.
In Januray 2025, Leica Biosystems has upgraded its Aperio GT 450 digital pathology scanner with features such as DICOM-compatible files, 20x/40x magnification, Z-Stacking, Manual Scan, and Extended Focus. Additionally, the enhanced Aperio iQC software now uses AI to identify digital and histological artifacts, further streamlining pathology workflows and boosting operational efficiency.
You may Also Like
https://www.skyquestt.com/report/mens-wear-market
https://issuu.com/skyquest-technology/docs/smart_energy_market_investment_insights_and_future/s/90090075
Forward-Looking Insights
The Digital Pathology Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]”
